Allen C. Ho from Wills Eye Hospital emphasizes the excitement in retinal research, highlighting advancements in translational science aimed at addressing common conditions like diabetic retinopathy and age-related macular degeneration (AMD). He shares insights on substantial resource investments in these areas as well as innovative treatments for inherited retinal degenerations. Ho confidently predicts significant gene therapy advancements in the coming years, building on the foundation established since the approval of Luxturna for retinal diseases.
False
Advertisement
False
Advertisement